Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.23.3
Condensed Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 42,350 $ 42,634
Accounts receivable (Note 9) 10,132 1,298
Contract assets and unbilled receivables (Note 9) 1,211 3,552
Prepaids and other current assets 484 1,453
Short-term investments 11 49
Total current assets 54,188 48,986
Property and equipment, net 3 6
Total assets 54,191 48,992
Current liabilities:    
Accounts payable 1,890 1,069
Accrued expenses 1,926 1,684
Derivative liability 93 0
Total current liabilities 3,909 2,753
Total liabilities 3,909 2,753
Commitments and contingencies (Note 3 and Note 8)
Stockholders' equity    
Preferred stock, par value $0.0001; 10,000,000 shares authorized as of September 30, 2023 and December 31, 2022; no shares issued and outstanding at September 30, 2023 and December 31, 2022. 0 0
Common stock, par value $0.0001; 75,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 22,610,131 and 20,861,315 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively. 2 2
Additional paid-in capital 126,951 117,717
Accumulated deficit (76,671) (71,480)
Total stockholders' equity 50,282 46,239
Total liabilities and stockholders' equity $ 54,191 $ 48,992